CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

A real-world report showed the safety and efficacy of zanubrutinib after a community oncology practice replaced ibrutinib with the newer Bruton tyrosine kinase inhibitor on its formulary. A bevy of ...

Your health insurance plan includes a list called a formulary -- a directory of the drugs it covers. If you've ever been stunned at how much it cost you to fill a prescription, it’s possible that ...

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and Tymlos. Like Humira and its biosimilars, Prolia is a specialty drug ...

Eli Lilly (LLY) stock is in focus as CVS Health (CVS) restores Zepbound coverage effective Oct 1, 2026, and adds Foundayo to ...

Laurie Wesolowicz, PharmD, director, pharmacy services clinical, Blue Cross Blue Shield of Michigan (BCBSM), says that clinical evidence and other factors can drive formulary decision-making. Evidence ...

CVS Caremark, one of America’s most powerful pharmacy benefit managers, will begin covering more GLP-1 medications again ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish plan-level metrics describing how beneficiaries’ use of medications is impacted by ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...